Loading clinical trials...
Loading clinical trials...
Effects of Repeated Use of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot in Stroke Patients: A Randomized Clinical Trial
Conditions
Interventions
IncobotulinumtoxinA
OnabotulinumtoxinA
Locations
1
Spain
Hospital de l'Esperança
Barcelona, Spain
Start Date
January 1, 2015
Primary Completion Date
June 30, 2017
Completion Date
September 30, 2017
Last Updated
October 20, 2017
NCT06998485
NCT05945212
NCT07073287
NCT07098286
NCT07106190
NCT05330234
Lead Sponsor
Parc de Salut Mar
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions